Trials / Completed
CompletedNCT04182880
Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain
Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain After Mini-abdominoplasty Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Cali Pharmaceuticals LLC · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in patients after mini-abdominoplasty
Detailed description
This is a randomized, double-blind, study to evaluate the safety, PK profile of CPL-01 for the management of postoperative pain after mini-abdominoplasty surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CPL-01 | CPL-01 will be administered |
| DRUG | Placebo | Placebo will be administered |
Timeline
- Start date
- 2020-01-06
- Primary completion
- 2020-02-28
- Completion
- 2020-02-28
- First posted
- 2019-12-02
- Last updated
- 2026-04-13
- Results posted
- 2022-09-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04182880. Inclusion in this directory is not an endorsement.